{"brief_title": "Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer", "brief_summary": "The purpose of this study is to compare overall survival in patients with previously-treated metastatic, epidermal growth factor receptor (EGFR)-positive colorectal cancer treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX4) and cetuximab with FOLFOX4 alone.", "condition": ["Colorectal Cancer"], "intervention_type": ["Biological", "Drug", "Drug", "Drug", "Drug", "Biological"], "intervention_name": ["cetuximab", "oxaliplatin", "leucovorin", "5-fluorouracil", "5-fluorouracil", "cetuximab"], "description": ["400 mg/m2 IV", "85 mg/m2 IV", "200 mg/m2 IV", "400 mg/m2 IV", "600 mg/m2 IV", "250 mg/m2 IV"], "arm_group_label": ["Cetuximab+FOLFOX4", "Cetuximab+FOLFOX4", "FOLFOX4.", "Cetuximab+FOLFOX4", "FOLFOX4.", "Cetuximab+FOLFOX4", "FOLFOX4.", "Cetuximab+FOLFOX4", "FOLFOX4.", "Cetuximab+FOLFOX4"], "other_name": ["Erbitux\u2122", "Eloxatin\u00ae", "Wellcovorin\u00ae", "5-FU", "5-FU", "Erbitux\u2122"], "criteria": "Inclusion Criteria: - Documented colorectal cancer which is EGFR-positive and is metastatic. - Prior irinotecan, alone or in combination, as first-line treatment of metastatic disease. Exclusion Criteria: - A serious uncontrolled medical disorder that, in the opinion of the Investigator, would impair the ability of the subject to receive protocol therapy. - Known dihydropyrimidine dehydrogenase (DPD) deficiency. - Known metastases in the central nervous system. - Symptomatic sensory or peripheral neuropathy. - More than one prior chemotherapy regimen for the treatment of metastatic colorectal cancer. - Prior oxaliplatin therapy. - Prior cetuximab or other therapy which targets the EGF pathway. - Prior chimerized or murine monoclonal antibody therapy.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Colorectal Neoplasms", "Oxaliplatin", "Cetuximab", "Fluorouracil"], "id": "NCT00061815"}